News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
01 13 2015 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2014 results on Thursday,...
-
01 08 2015 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the appointment of veteran health plan executive Michael Cole as vice president of...
-
01 06 2015 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 33rd Annual J.P. Morgan Healthcare...
-
01 05 2015 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Goldman Sachs Healthcare CEOs Unscripted...
-
12 09 2014 As the 2014-2015 flu season begins, Focus Diagnostics, the products business of Quest Diagnostics (NYSE: DGX), today announced that its Simplexa™ Flu A/B & RSV Direct Kit has received FDA...
-
12 04 2014 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.33 per share,...
-
12 01 2014 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Piper Jaffray 26th Annual Healthcare...
-
11 05 2014 - Company Expects to Generate 2% to 5% Revenue Growth and Adjusted Diluted EPS Growth of 8% to 10% on Average Over Next Three Years -At a meeting with analysts and investors at its Investor Day here today, members of the senior management team of Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of...
-
11 04 2014 First major service extension to the company's BRCAvantage™ BRCA1 and BRCA2 mutation test menu offers screening for five new non-BRCA genes shown to increase risk of inherited breast cancerQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced BRCAvantage Plus, the company's first suite of lab-developed test services for...
-
10 23 2014 Revenues from continuing operations of $1.9 billion, up 6.5% versus prior year Adjusted diluted EPS from continuing operations of $1.10, up 7.8% versus prior year Reported diluted EPS from...
-
10 22 2014 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Jeffrey M. Leiden, M.D., Ph.D., to serve as...
-
10 07 2014 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2014 results on Thursday, October 23, 2014, before the...
-
10 02 2014 Congresswoman Niki Tsongas, Representative Danielle Gregoire and Marlborough Mayor Arthur Vigeant join community event to open 200,000 square-foot "lab of the future" designed to deliver innovative, efficient diagnostic information services to New EnglandQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today unveiled its new, state-of-the-art clinical test laboratory in Marlborough, Massachusetts with...
-
10 01 2014 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, will host Investor Day for institutional investors and financial analysts...
-
10 01 2014 Former president and CEO of Mayo Medical Laboratories and chair of lab medicine and pathology for Mayo Clinic to oversee Quest's clinical testing operationsQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that Franklin R. Cockerill, III, M.D., has joined the company as vice president and...
-
09 12 2014 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today celebrates a decade on the North America Dow Jones Sustainability Index (DJSI) and 11...
-
09 11 2014 Colorado and Washington experience surges in marijuana tests positivity rate, but data suggests state legalization of recreational marijuana may not be sole driver of increasesThe percentage of positive drug tests among American workers has increased for the first time in more than a decade, fueled by a rise in marijuana and amphetamines, according to an analysis of 8.5...
-
09 08 2014 Clinical testing volume and positivity rate both grew after the first case of the infectious disease spread to Western Hemisphere this yearA growing number of patients in the United States are being tested – and testing positive – for the mosquito-borne chikungunya virus, according to a study presented at the Interscience...
-
09 04 2014 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare...
-
08 27 2014 Testing for the protein 14-3-3eta may improve the diagnosis of RA, including in early stages when treatment is most likely to improve outcomesA novel biomarker for rheumatoid arthritis (RA) has significant potential to help physicians better identify early-stage disease, when treatment can often arrest further disease progression and...
-
08 15 2014 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.33 per share,...
-
07 24 2014 Revenues from continuing operations of $1.9 billion, up 4.8% versus prior year Adjusted diluted EPS from continuing operations of $1.08, up 1.9% versus prior year Reported diluted EPS from...
-
07 23 2014 Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Vicky Gregg to serve as a director, effective...
-
07 16 2014 Three-year analysis of more than 1.4 million test results also shows majority of Americans continue to put health at risk through dangerous drug combinations and skipping dosesFive states that have implemented multi-faceted prescription drug abuse prevention programs in recent years showed the highest rate of decline in prescription drug misuse rates nationwide,...
-
07 07 2014 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2014 results on Thursday, July 24, 2014, before the...
-
06 10 2014 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today introduced a new cancer test service based on the FDA-approved THxID®-BRAF test from...
-
06 04 2014 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Goldman Sachs 35th Annual Global...
-
06 01 2014 Diagnostic insights into gene mutations in solid tumor cancers will aid therapy selection and prognosis for patients and advance researchMemorial Sloan Kettering Cancer Center, the world's oldest and largest private cancer center, and Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services,...
-
05 21 2014 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.33 per share,...
-
05 05 2014 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Deutsche Bank 39th Annual Heath Care...
-
04 28 2014 Company scientists advance understanding of role of genetics in seizure disorders, Charcot-Marie-Tooth disease and other conditions at top neurology industry conferenceQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that several scientists from its Athena Diagnostics specialty neurology business...
-
04 24 2014 Full year revenue and adjusted earnings per diluted share guidance unchanged First quarter adjusted diluted EPS from continuing operations of $0.84, vs. $0.89 in 2013 First quarter adjusted...
-
04 23 2014 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Steward Health Care System LLC (Steward), New England's largest community-based accountable care...
-
04 23 2014 Test test test test twoQuest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, has signed a definitive agreement to manage the clinical testing laboratory at Charlotte Hungerford Hospital, a general acute care hospital in Torrington, Connecticut.
-
04 23 2014 Quest Diagnostics' specialty neurology business unveils 10 new epilepsy diagnostic services, including industry's first clinical multi-analyte test for autoimmune epilepsyQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced a suite of new testing services from its Athena Diagnostics specialty neurology...
-
04 21 2014 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, has completed the previously announced acquisition of Summit Health, a leading provider of on-site...
-
04 07 2014 Company launches new website to enable patients to access lab data under federal rule that takes effect todayFor the first time, Americans nationwide can directly access their personal laboratory data through Quest Diagnostics (NYSE: DGX), the world's leading...
-
04 03 2014 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2014...
-
03 24 2014 Quest Diagnostics business launches first HSV PCR for CSF in United States. Test provides results in about 60 minutes.Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information and services, today announced that its Focus...
-
03 12 2014 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it intends to offer...
-
03 11 2014 Combined Offering to Accelerate Growth from Prevention and Wellness ProgramsQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has entered into a definitive...
-
03 10 2014 - Full Year 2014 Revenues expected to grow 2% - 4% compared to 2013Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has completed the previously...
-
02 26 2014 Company Supports March's Colorectal Cancer Awareness Month by Participating in the One Million Strong Screening Event in New York City on March 3Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced new pathology and blood test...
-
02 24 2014 Retired New York Giants Player Stephen Baker to Join Quest as it Provides 100 Complimentary Blueprint for Wellness® Profiles at Booth 3064 on February 25Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, will exhibit at booth 3064 and host a series of "Tech...
-
02 17 2014 -- John B. Haydon transitions to Vice President, Joint Ventures and Strategic ProgramsQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced a series of senior leadership...
-
02 14 2014 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at...
-
02 12 2014 Enabling Health Systems to Qualify for CMS Financial IncentivesChartMaxx, the enterprise content management (ECM) solution from Quest Diagnostics (NYSE:DGX), has achieved 2014 Edition Modular EHR*...
-
02 05 2014 ChartMaxx Enterprise Content Management System Honored with Top Ranking for the Ninth TimeQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that its ChartMaxx® enterprise...
-
02 04 2014 The Quest Diagnostics Health Trends™ study of 2.7 million test results is the largest to examine warfarin treatment in patients with atrial fibrillation (Afib) treated in primary care and other non-hospital care settings in the United StatesApproximately one in two patients with atrial fibrillation (Afib) do not optimally reduce their risk of stroke or bleeding when treated with the most...
-
02 03 2014 A final rule issued today by the U.S. Department of Health and Human Services (HHS) giving Americans increased access to their personal health...
-
01 30 2014 Fourth quarter adjusted diluted EPS from continuing operations of $1.03, 2% above prior year Fourth quarter reported diluted EPS from continuing...
-
01 22 2014 Transaction to give patients and healthcare providers in the Southeastern United States greater access to innovative and cost-effective diagnostic information servicesQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has entered into a definitive...
-
01 17 2014 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full...
-
01 13 2014 Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected...
-
01 10 2014 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at...
-
01 09 2014 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and the University of California, San...
-
12 12 2013 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today updated its estimates for full-year 2013 revenues...
-
12 09 2013 Quest and Alamo Breast Cancer Foundation also Co-Hosting Panel on "Cancer and BRCA Testing in the News, the Arts and Popular Culture," Joined by Director of Upcoming Film "Decoding Annie Parker"Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that BRCAvantage™, a service-rich oncology...
-
12 06 2013 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a...
-
11 26 2013 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at...
-
11 18 2013 Landmark Drug Testing Index™ analysis from Quest Diagnostics coincides with passage of the Drug-Free Workplace Act 25 years ago todayDrug use among American workers declined dramatically over the past 25 years, although the rate of positive test results for certain drugs, including...
-
11 08 2013 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at...
-
10 17 2013 Adjusted diluted EPS from continuing operations of $1.02, vs. $1.15 in 2012 Reported diluted EPS from continuing operations of $2.66, vs. $0.98 in 2012...
-
10 15 2013 Also Releases Results from National Harris Survey Revealing Widespread Confusion about BRCA TestingQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of BRCAvantage™,...
-
10 15 2013 Seventy-two Percent (72 percent) of Adult Women in the U.S. Have Never Heard of BRCA Testing, yet 58 Percent Would Want to Know if They Carried High-Risk Gene MutationsAccording to the results of a recent Quest Diagnostics (NYSE: DGX) survey, seventy-two percent (72 percent) of American women age 18 and older have...
-
10 10 2013 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today provided a preview of revenues and earnings per...
-
10 07 2013 Transaction to expand patient access to innovative diagnostic information services and bolster Quest's growth strategy in New EnglandQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has acquired...
-
10 03 2013 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, has again been named to the Dow Jones Sustainability...
-
10 02 2013 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2013 results on
-
10 01 2013 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that on September 30, 2013...
-
09 06 2013 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak...
-
08 20 2013 Increase brings total current authorization to approximately $1.3 billionQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of...
-
08 20 2013 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a...
-
08 14 2013 Quest's electronic health record ranked number one for overall satisfaction across all physician categories; also ranked number one for mobile innovation and accessQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Care360 cloud-based...
-
08 08 2013 Believed to be first clinical test to identify variants of four enzymes that mediate drug metabolism, providing greater insights for guiding treatment for the more than 100 million Americans with chronic painQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of a new lab-developed...
-
07 26 2013 Volunteer Team Urges City Residents and Visitors to Come Out, Be Counted, and Paint at Hepatitis Awareness Event, Chinatown Park, 10:00 a.m. on July 28th.Students at Harvard, Massachusetts Institute of Technology and Brown University, Massachusetts Asian & Pacific Islanders (MAP) for Health and local employee...
-
07 25 2013 Giants Training Facility and Headquarters Renamed Quest Diagnostics Training CenterQuest Diagnostics (NYSE: DGX) and the New York Giants are teaming up to find new ways to use laboratory diagnostic information services to...
-
07 18 2013 Adjusted diluted EPS from continuing operations of $1.06, vs. $1.15 in 2012 Reported diluted EPS from continuing operations of $0.99, vs. $1.09 in 2012...
-
07 18 2013 Retains royalty rights to odanacatib and other Celera drug assetsQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has...
-
07 17 2013 Quest Diagnostics Incorporated (NYSE: DGX) today announced that Mark J. Guinan will join the company on July 29 as its next Senior Vice President...
-
07 10 2013 Collaboration aims to improve health outcomes for the estimated 3.2 million Americans infected with hepatitis CQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced a collaboration with the U.S. Centers...
-
07 02 2013 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2013...
-
06 26 2013 Goal to facilitate greater provider access to secure health data, promoting greater care coordination and improved cost efficienciesQuest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced an agreement with AT&T* to provide the...
-
06 24 2013 Acquisition consistent with strategy to drive one to two percent in growth per year through strategically aligned fold-in acquisitionsQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has...
-
06 06 2013 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that Steve Rusckowski, President...
-
06 06 2013 Collaboration features national availability of the APTIMA HPV mRNA-based cervical cancer screening test as well as a focus on developing and expanding access to diagnostic solutions for women's healthQuest Diagnostics (NYSE: DGX), the world's leading diagnostic information services company, and Hologic, Inc. (Hologic) (NASDAQ:...
-
06 05 2013 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that Steve Rusckowski, President...
-
05 21 2013 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a...
-
05 16 2013 Patients, physicians and employers to benefit from greater access to broader menu of innovative diagnostic information servicesQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has acquired the toxicology and...
-
05 13 2013 Largest study of LDL blood levels, based on tests of nearly 105 million Americans, suggests improvements in cardiovascular health may have stalled in recent yearsDecades of declines in LDL cholesterol blood levels, a key marker of death risk from heart disease, abruptly ended in 2008, and may have stalled since,...
-
05 07 2013 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at...
-
04 17 2013 Adjusted diluted EPS from continuing operations of $0.89, vs. $1.05 in 2012 Reported diluted EPS from continuing operations of $0.72, vs. $0.97 in...
-
04 17 2013 Transaction expected to deliver innovative and high-quality diagnostic information services at lower costs to patientsQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has entered...
-
04 16 2013 Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, announced today that Jim Davis, a former vice...
-
04 09 2013 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has completed the sale of its...
-
04 09 2013 Based on 14-3-3eta protein biomarker for aiding early RA diagnosis through an exclusive license with Augurex Life SciencesQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of two new blood tests...
-
04 08 2013 Quest Diagnostics Health Trends™ analysis also finds marijuana is the most commonly abused drug in the United States, but medical marijuana users are not more likely to misuse other drugsIndividuals who use marijuana recreationally are more likely to misuse other drugs, including pain-controlling, but potentially addictive narcotics,...
-
04 05 2013 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2013...
-
04 03 2013 Quest Diagnostics Health Trends™ analysis of a quarter million test results finds three out of five Americans tested misused their prescription medications, including through potentially dangerous drug combinationsDespite increased public attention on the epidemic of prescription medication abuse, about three in five Americans tested misused their prescription...
-
04 02 2013 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that Sukumar Nagendran, M.D., has...